Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Oct 12 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-12-2023-5

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases